Ghent University Academic Bibliography

Your filters: cql: author="Boer, W" or (type any "bookEditor issueEditor" and editor="Boer, W")

Add to list
- Journal Article
- A1
- open access
Unapparent systemic effects of regional anticoagulation with citrate in continuous renal replacement therapy : a narrative review

W Boer, W Verbrugghe, Eric Hoste (UGent) , R Jacobs and PG Jorens

(2023) ANNALS OF INTENSIVE CARE. 13(1).
Add to list
- Journal Article
- A1
- open access
Description and performance of track and primary-vertex reconstruction with the CMS tracker

S Chatrchyan, V Khachatryan, AM Sirunyan, A Tumasyan, W Adam, T Bergauer, M Dragicevic, J Ero, C Fabjan, M Friedl, et al.

(2014) JOURNAL OF INSTRUMENTATION. 9.
Add to list
- Journal Article
- A1
Reduced complications during hemodialysis by automatic blood volume controlled ultrafiltration

D GARZONI, G KEUSCH, T KLEINOEDER, H MARTIN, Annemieke Dhondt (UGent) , L CREMASCHI, E TATSIS, N IBRAHIM, W BOER, S KUEHNE, et al.

(2007) INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS. 30(1). p.16-24
Add to list
- Conference Paper
- C3
Less problems with hypotension-prone hemodialysis patients by blood volume control

H MARTIN, Annemieke Dhondt (UGent) , M CLAUS, T KLEINOEDER, L CREMASCHI, H HICKSTEIN, W BOER, G KEUSCH, S KUEHNE, E TATSIS, et al.

(2005) NEPHROLOGY DIALYSIS TRANSPLANTATION. 20.
Add to list
- Journal Article
- A1
A randomized clinical trial with a 0.6% amino acid/1.4% glycerol peritoneal dialysis solution

Wim Van Biesen (UGent) , W BOER, B DE GREVE, Clement Dequidt (UGent) , DENISE VIJT (UGent) , D FAICT and Norbert Lameire (UGent)

(2004) PERITONEAL DIALYSIS INTERNATIONAL. 24(3). p.222-230

Academic Bibliography

Unapparent systemic effects of regional anticoagulation with citrate in continuous renal replacement therapy : a narrative review

Description and performance of track and primary-vertex reconstruction with the CMS tracker

Reduced complications during hemodialysis by automatic blood volume controlled ultrafiltration

Less problems with hypotension-prone hemodialysis patients by blood volume control

A randomized clinical trial with a 0.6% amino acid/1.4% glycerol peritoneal dialysis solution

Contents

Support

Contact